argenx: Steritas and argenx join forces to advance steroid-sparing therapeutic development
With the help of Steritas' STOX Suite, argenx aims to develop antibody-based therapeutics for immune diseases, potentially allowing patients to move away from chronic steroid usage
Read full article »
argenx is a Netherland-based biotechnology company that develops and commercializes immunotherapeutics for the treatment of autoimmune diseases.
Read more